Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia

NCT01490567 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT01490567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01490567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
Lead sponsor
Central South University
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2011
Completion date
June 30, 2012
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired cognition, schizophrenia